Synthetic molecules deliver drugs directly to neuroblastoma
06 June, 2019Researchers synthesised a family of molecules that are able to specifically bind a protein found in the cell membrane of more than 90% of neuroblastoma cells.
Stem cell therapy can reverse osteoarthritis
05 June, 2019Pure stem cells provide a more effective treatment for osteoarthritis than traditional therapies, such as pain relief drugs, anti-inflammatories, prescribed exercise and knee surgery.
Cell culture platform recreates tumours in 3D
29 May, 2019Scientists can use a 3D tumour structure to test several drugs or their combinations at different stages of the tumour's development.
Scientists combine influenza and pneumococcal vaccines
23 May, 2019Scientists have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections, while enhancing protection against both.
Biological tissue could be 3D printed
21 May, 2019Researchers have been working to develop and optimise suitable bioinks for additive manufacturing, in the hope that we will soon be using 3D-printed biologically functional tissue to replace irreparably damaged tissue in the body.
Synthetic polymyxin antibiotics could take on superbugs
16 May, 2019Monash University has granted an exclusive licence of its portfolio of proprietary synthetic polymyxin antibiotics to Qpex Biopharma.
Cancer cells tricked into defective reproduction
15 May, 2019A 'triple combination' of vitamin C and two standard antibiotics — doxycycline and azithromycin — was sufficient to reduce stem cell growth by more than 90% in laboratory tests.
DNA folded into a nanocapsule for drug delivery
01 May, 2019Finnish researchers have developed a customised DNA nanostructure that can perform a predefined task in human body-like conditions.
Natural antibiotic genetically engineered from fungus
15 April, 2019Researchers have used genetic engineering to turn a fungus into a natural antibiotic — one which could serve as a promising cure for a neglected tropical disease.
Ovarian cancer trial shows positive results
11 April, 2019Kazia Therapeutics has summarised data from Part A of its ongoing phase I study of Cantrixil in ovarian cancer — a study which has so far seen promising results.
Miniature hearts used to test potential new drugs
10 April, 2019Australian scientists have conducted what is claimed to be the first ever screening of potential heart regeneration drugs using bioengineered human heart muscle.
Anti-TB drugs can actually increase risk of TB reinfection
05 April, 2019Anti-TB drugs cause changes to gut microbiota, increasing susceptibility to Mycobacterium tuberculosis infection as a result.
Potential male birth control pill passes human safety tests
03 April, 2019US scientists have announced promising results from their recent trial of an experimental male oral contraceptive.
'Antibiotic envelope' cuts infection risk from cardiac devices
27 March, 2019Encasing implantable cardiac devices such as pacemakers in a mesh sleeve embedded with antibiotics reduces the risk of major infection by 40%.
Pharmaceutical manufacturing and obsolescence management
19 March, 2019For many pharmaceutical manufacturing processes, often very old equipment or technology is still being used.
